InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Jacques Rachelle Suzanne, 董事. Director active across 4 companies, notably uniQure N.V.. Cumulatively, 12 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €44k. Activity tracked since 24 February 2022. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Jacques Rachelle Suzanne is Administrateur at uniQure N.V. and Corbus Pharmaceuticals Holdings, Inc., and Chief Executive Officer at Akari Therapeutics Plc. The declarant has 12 filings in total, and across the sampled recent filings from 2022-02-28 to 2026-05-21, sales amount to EUR 44422 and purchases amount to EUR 0.